Search clinical trials for: Switching to NPH insulin

Total 217 results

Massachusetts General Hospital
Sanofi

Completed

Comparison of Lantus and Neutral Protamine Hagedorn (NPH) Insulin in the Dawn Phenomenon (DAWN)

Type 1 Diabetes | Dawn Phenomenon

United States
Norwegian University of Science and Technology

Completed

Treatment of Latent Autoimmune Diabetes of the Adult (LADA)

Diabetes

Norway
Vanderbilt University Medical Center

Completed

Ghrelin and Insulin Resistance

Obesity | Insulin Resistance | Normal Weight,Healthy Controls

United States
Assiut University

Not yet recruiting

Insulin Resistance in Egyptian Patients With Multiple Sclerosis (IR-MS)

Multiple Sclerosis | Insulin Resistance
Gangnam Severance Hospital

Completed

Effect of Oral Carbohydrate on Serum S-100β Protein and Development of Postoperative Delirium in Elderly Patients

Inflammation | Delirium | Insulin Resistance
Niguarda Hospital

Completed

Lypo-hypertrofia Characterization in Diabetes

Type 1 Diabetes Mellitus

Italy
Mayo Clinic

Terminated

A Program of Physician Supervision to Improve the Quality of Patient Referrals From Nurse Practitioners and Physician Assistants

Complex Patients

United States
Pfizer

Completed

Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular Safety (VOLUME)

Diabetes Mellitus

United States, Germany, Sweden, United Kingdom, Puerto Rico
University Hospital, Toulouse
Ministry of Health, France; Agence Régionale de la Santé - Midi Pyrénées

Completed

Factors Predisposing to Inappropriate Transfers of Nursing Home Residents to Emergency Departments (FINE)

Frail Elderly

France
Hospices Civils de Lyon

Terminated

Individualized Blood Glucose Control in ICU. The CONTROLING Study. A Double Blinded Multicentric Randomized Study. (CONTROLING)

Critical Illness

France
Saglik Bilimleri Universitesi
Medical Park Hospital Istanbul

Completed

Effect of Neurophysiological Facilitation Techniques in Intensive Care Patients

Intensive Care Unit Acquired Weakness | Intensive Care (ICU) Myopathy

Turkey
University of Texas Southwestern Medical Center

Completed

The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study (SIMPLE)

Diabetes Mellitus, Type 2 | Diabetes

United States
Nanjing First Hospital, Nanjing Medical University

Recruiting

Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

China
Nanjing First Hospital, Nanjing Medical University

Unknown

Effects of Replacing Lantus With Basalin on the Glycemic Variation in Patients With Type 2 Diabetes Mellitus

Type2 Diabetes

China
Emory University

Completed

Sitagliptin in Non-Diabetic Patients Undergoing Cardiac Surgery (SITACABG NonDM)

Coronary Artery Disease

United States
University Hospital, Ghent

Completed

Adherence, Efficacy and Safety of an Insulin Protocol in the Critically Ill: A Prospective Observational Study

Critically Ill Patients

Belgium
Adocia

Completed

A Trial to Compare BioChaperone Insulin Lispro Formulations With US Approved Humalog® and With EU Approved Humalog® in Patients With Type 1 Diabetes Mellitus

Type 1 Diabetes

Germany
Merck Sharp & Dohme LLC

Completed

A Study of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019)

Type 2 Diabetes Mellitus
Chiang Mai University

Unknown

Neurocognitive Function Improvement After Switching From Efavirenz to Rilpivirine

HIV-1-infection | Neurocognitive Dysfunction

Thailand
Virginia Commonwealth University

Terminated

Efficacy of a Patient Education Video

Malignant Neoplasm | Leukemia, Not Otherwise Specified

United States
Oslo University Hospital
University of Oslo; Norwegian Foundation for Health and Rehabilitation

Completed

Guidance in Diet and Physical Activity for Prevention of Weight Gain After Gastric Bypass Surgery

Obesity

Norway
Wake Forest University Health Sciences

Active, not recruiting

Study of Nasal Insulin to Fight Forgetfulness - Device Study

Cognitive Impairment | Mild Cognitive Impairment

United States
University of Alabama at Birmingham

Recruiting

Pulmonary Vascular Hemodynamics Before and After Mitral Valve Procedures

Pulmonary Hypertension

United States
Albert Einstein College of Medicine
Medtronic

Completed

Randomized Trial Comparing Sitagliptin to Placebo in Closed Loop

Diabetes Mellitus, Type 1

United States
University of Sao Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo; Conselho Nacional de...

Completed

Functional Ingredients: Effect in Gastrointestinal System

Diabetes | Overweight | Constipation

Brazil
Eli Lilly and Company

Completed

Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY) (IOOY)

Diabetes Mellitus Type 2

Korea, Republic of, Hungary, United States, Mexico, Argentina, India, Poland, Taiwan, Spain
Yonsei University

Unknown

Switch From Adefovir to Tenofovir in Chronic Hepatitis B for Suboptimal Response to Adefovir-based Combination Therapy

Chronic Hepatitis B

Korea, Republic of
Sun Yat-sen University
Yangxi people hospital, Yangjiang, Guangdong Province

Completed

Information, Networks and Rewards to Optimise Adherence to Diabetic Services (INROADS)

Diabetes

China
KU Leuven
Novo Nordisk A/S; Fund for Scientific Research, Flanders, Belgium

Completed

KULeuven Intensive Insulin Therapy Study in Medical Intensive Care Patients

Critical Illness

Belgium
Institut de Recherches Cliniques de Montreal

Completed

Prevention of Mild-to-moderate Hypoglycemia in Type 1 Diabetes (REVERSIBLE)

Type 1 Diabetes

Canada
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety, Tolerability, and Efficacy of the Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Therapy (MK-3102-024)

Type 2 Diabetes Mellitus
Wake Forest University Health Sciences

Active, not recruiting

SNIFF Multi-Device Study 2

Cognitive Impairment | Mild Cognitive Impairment

United States
Shionogi

Completed

Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Patients With Influenza at High Risk of Influenza Complications (CAPSTONE 2)

Influenza
University of Saskatchewan
Saskatchewan Health Research Foundation; Ralston Brothers Grant (Kelsey Trail...

Completed

Investigation of a Physiotherapist and Nurse Practitioner Intervention for Chronic Low Back Disorders Delivered Through Telehealth

Chronic Low Back Pain

Canada
T.C. ORDU ÜNİVERSİTESİ

Completed

The Relationship Between COVID-19 Anxiety Level and Emotional Eating in Individuals With Metabolic Syndrome (COVID-19)

COVID-19 | Metabolic Syndrome | Emotional Eating

Turkey
University of Minnesota

Completed

Post-Gastric Bypass Hypoglycemia

Hyperinsulinemic Hypoglycemia

United States
Merck Sharp & Dohme LLC

Completed

Single Ascending Dose Study of MK-1092 in Healthy Participants and in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-1092-001)

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus

United States
Merck Sharp & Dohme LLC

Completed

A Pooled Analysis of the Safety and Efficacy of MK-0431A and MK-0431A XR in Pediatric Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Therapy (Alone or in Combination With Insulin) (MK-0431A-170/MK-0431A-289)

Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC
Pfizer

Active, not recruiting

Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059)

Type 2 Diabetes Mellitus

United States, Belgium, Canada, Colombia, Costa Rica, Dominican Republic, France, Guatemala, Hungary, Israel, Italy, Malaysia, Mauritius, Mexico, Philippines, Poland, Russian Federation, Saudi Arabia, Turkey, Ukraine, United Arab... and more
Medstar Health Research Institute
GlaxoSmithKline

Completed

Switching From Fondaparinux to Bivalirudin or Unfractionated Heparin in ACS Patients Undergoing PCI (SWITCHIII)

Acute Coronary Syndromes

United States, Canada
State University of New York at Buffalo
Juvenile Diabetes Research Foundation; University of Glasgow

Recruiting

Triple Therapy in T1DM

Type 1 Diabetes Mellitus

United States
University of California, San Francisco

Completed

Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy?

Type 2 Diabetes Mellitus

United States
Merck Sharp & Dohme LLC

Completed

A Study of the Safety and Efficacy of Omarigliptin (MK-3102) Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)

Type 2 Diabetes Mellitus
Cardiff University

Completed

Enhanced Epidermal Antigen Specific Immunotherapy Trial -1 (EE-ASI-1)

Type 1 Diabetes

United Kingdom
Merck Sharp & Dohme LLC

Completed

Randomized Sitagliptin Withdrawal Study (MK-0431-845)

Type 2 Diabetes Mellitus
The University of Texas Medical Branch, Galveston
National Institute of General Medical Sciences (NIGMS)

Completed

Assessment of Mechanisms of Improved Wound Healing

Burns

United States
Merck Sharp & Dohme LLC

Completed

Multiple Ascending Dose Study of MK-5160 in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-5160-002)

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus

United States
Medstar Health Research Institute

Completed

Stop Emergency Room Visits for Hyperglycemia Project - District of Columbia (DC) (STEP-DC)

Type 2 Diabetes Mellitus

United States
Klinički Bolnički Centar Zagreb
University of Zagreb

Recruiting

Switching From the Preserved to the Preservative - Free Latanoprost - Timolol FC in Glaucoma Patients With OSD

Ocular Hypertension | Primary Open-angle Glaucoma

Croatia
Merck Sharp & Dohme LLC
Pfizer

Completed

Ertugliflozin and Sitagliptin Co-administration Factorial Study (VERTIS FACTORAL, MK-8835-005)

Type 2 Diabetes Mellitus

Search clinical trials for: Switching to NPH insulin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hungary

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations